Avience Biomedicals Confirms Corporate Governance Non-Applicability For Q2 FY27
Avience Biomedicals Ltd 路 Others (Uncategorized) 路 29 Oct 2026, 12:23 am
Avience Biomedicals Confirms Corporate Governance Non-Applicability For Q2 FY27 Avience Biomedicals Limited notified the National Stock Exchange on 28th Oct'26 that corporate governance compliance provisions under SEBI (LODR) Regulations, 2015 are not applicable to the company for the quarter ended 30th Sep'26. As an entity listed on the NSE Emerge SME platform, the company is exempt under Regulation 15(2)(b), thereby removing the requirement to submit quarterly corporate governance reports. The filing was supported by a certification from practicing company secretary firm G.R. Gupta & Associates.
Original exchange filing (PDF)
More announcements from Avience Biomedicals Ltd
- Avience Biomedicals Limited has informed the Exchange about Link of Recording 路 18 Nov 2026
- Avience Biomedicals Limited has informed the Exchange about Investor Presentation 路 14 Nov 2026
- Avience Biomedicals Limited has informed the Exchange about Schedule of meet 路 12 Nov 2026
- Avience Biomedicals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 11 Nov 2026
- Avience Biomedicals Limited has informed the Exchange about Board Meeting to be held on 10-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 10 Nov 2026
- To consider and approve the Standalone & Consolidated financial results for the period ended September 30, 2026 路 10 Nov 2026
- Avience Biomedicals Limited has informed the Exchange about Outcome of Investor Conference 路 02 Oct 2026
- Avience Biomedicals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results. 路 01 Oct 2026
